Catherine Coomer
Family · Charlestown, INNPI 1851379887
Payments from drug & device makers
Across 222 payments — averaging $19.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$989
- AbbVie$648
- Otsuka America Pharmaceutical, Inc.$377
- Idorsia Pharmaceuticals US Inc$226
- Lundbeck LLC$211
- Lilly USA, LLC$204
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,384100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 41 | $989 |
| AbbVie | 46 | $648 |
| Otsuka America Pharmaceutical, Inc. | 18 | $377 |
| Idorsia Pharmaceuticals US Inc | 9 | $226 |
| Lundbeck LLC | 8 | $211 |
| Lilly USA, LLC | 10 | $204 |
| Bayer | 10 | $201 |
| Axsome Therapeutics, Inc. | 8 | $187 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $150 |
| Novo Nordisk | 9 | $143 |
| GSK | 7 | $123 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $94 |
| Mylan Specialty L.p. | 3 | $74 |
| Exact Sciences | 3 | $73 |
| Amgen | 3 | $64 |
| Vanda Pharmaceuticals Inc. | 2 | $56 |
| Merck | 3 | $54 |
| Pfizer | 3 | $49 |
| Sumitomo Pharma America, Inc. | 3 | $47 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $45 |
| Alkermes, Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Sunovion Pharmaceuticals Inc. | 2 | $37 |
| Shield Therapeutics Inc | 2 | $34 |
| Verona Pharma, Inc. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| Ardelyx, Inc. | 1 | $27 |
| Nevro Corp. | 1 | $23 |
| Abbott | 1 | $22 |
| Novartis | 1 | $18 |
| Tris Pharma Inc | 1 | $17 |
| Almatica Pharma LLC | 1 | $15 |
| Tolmar, Inc. | 1 | $15 |
| Impel Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,384 in reported general payments places this provider in the 90th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 52 | $61,571 |
| OzempicSemaglutide | 44 | $60,587 |
| VraylarCariprazine Hcl | 28 | $39,545 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 36 | $35,201 |
| TrulicityDulaglutide | 37 | $34,837 |
| FarxigaDapagliflozin Propanediol | 56 | $32,834 |
| RexultiBrexpiprazole | 15 | $26,270 |
| EliquisApixaban | 28 | $25,422 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 35 | $25,367 |
| JardianceEmpagliflozin | 16 | $11,969 |
| GemtesaVibegron | 15 | $8,893 |
| Repatha SureclickEvolocumab | 13 | $7,174 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 187 | $3,328 |
| Celecoxib | 33 | $3,138 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 74 | $2,044 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $204 | $96,40889 claims |
| Novo NordiskOzempic | $143 | $60,58744 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $989 | $58,20091 claims |
| AbbVieVraylar | $648 | $39,54528 claims |
| GSKTrelegy Ellipta | $123 | $35,20136 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $377 | $26,27015 claims |
| PfizerEliquis | $49 | $25,42228 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $47 | $8,89315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,392 family providers in Indiana.
Other family in Charlestown
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
- Nancy ArndtPortage$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.